News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
224 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17923)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (154)
2 (6)
3 (12)
4 (274)
5 (260)
6 (237)
7 (220)
8 (212)
9 (3)
10 (10)
11 (235)
12 (224)
13 (213)
14 (181)
15 (49)
16 (1)
18 (153)
19 (254)
20 (233)
21 (215)
22 (111)
23 (5)
24 (5)
25 (226)
26 (269)
27 (322)
28 (307)
29 (150)
30 (4)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
BlueWind Medical Ltd. Appoints Charles F. Cargile as Chief Financial Officer
BlueWind Medical, Ltd., developer of the innovative RENOVA iStim™ implantable tibial neuromodulation device for treatment of Overactive Bladder, announced the addition of Charles F. Cargile to its leadership team as Chief Financial Officer.
April 12, 2022
·
3 min read
Drug Development
MediLink Therapeutics Receives FDA Clearance of IND Application for YL201 Antibody Drug Conjugate Product
MediLink Therapeutics announced that YL201, the first compound based on MediLink’s proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its Phase I first-in-human study.
April 12, 2022
·
1 min read
Business
ALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board of Directors
ALX Oncology Holdings Inc. today announced the appointment of Itziar Canamasas, Ph.D., to its Board of Directors (the “Board”) effective April 11, 2022.
April 12, 2022
·
3 min read
BioMidwest
Bio-Techne and Cygnus Technologies, Part of Maravai Lifesciences, Introduce New Simple Plex HEK 293 HCP 3G Immunoassay
Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.
April 12, 2022
·
4 min read
Oncolytics Biotech® to Participate in a Fireside Chat at the Canaccord Genuity Horizons in Oncology Virtual Conference
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Thomas Heineman, M.D., Ph.D., the Company’s Chief Medical Officer, will be participating in a fireside chat at the Canaccord Genuity Horizons in Oncology Virtual Conference.
April 12, 2022
·
4 min read
Business
Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics
Persephone Biosciences Inc. and Ginkgo Bioworks today announced a collaboration to develop a novel therapeutics based on the bacterial genus Bacteroides.
April 12, 2022
·
5 min read
Drug Development
ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131 in Cholangiocarcinoma at AACR Annual Meeting 2022
ZielBio, Inc. will present new, preclinical data on the efficacy of its ZB131 drug in cholangiocarcinoma (CCA) models at the American Association for Cancer Research (AACR) Annual Meeting 2022.
April 12, 2022
·
3 min read
Drug Development
Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the initiation of a Phase 1/2 clinical study of DARE-HRT1.
April 12, 2022
·
11 min read
Recce Pharmaceuticals Announces Anti-Viral Patent Granted in Hong Kong for RECCE® Anti-Infectives
Recce Pharmaceuticals Limited is pleased to announce the Intellectual Property Department of the Hong Kong Special Administrative Region has granted patent family three, “Anti-Virus Agent and Method for Treatment of Viral Infection,” furthering marketing and manufacturing exclusivity to February 2037.
April 12, 2022
·
3 min read
Business
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
PerkinElmer, Inc. today announced that the Company will release its first quarter 2022 financial results after market close on Tuesday, May 3, 2022.
April 12, 2022
·
1 min read
Previous
21 of 23
Next